What is Minerva Neurosciences' stock symbol?
Minerva Neurosciences trades on the NASDAQ under the ticker symbol "NERV."
Where is Minerva Neurosciences' stock going? Where will Minerva Neurosciences' stock price be in 2017?
2 analysts have issued 12 month price targets for Minerva Neurosciences' shares. Their predictions range from $17.00 to $17.00. On average, they expect Minerva Neurosciences' share price to reach $17.00 in the next twelve months.
When will Minerva Neurosciences announce their earnings?
Minerva Neurosciences is scheduled to release their next quarterly earnings announcement on Monday, March, 13th 2017.
Who owns Minerva Neurosciences stock?
Minerva Neurosciences' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Federated Investors Inc. PA (18.27%), FMR LLC (14.31%), Highland Capital Management LP (3.28%), Franklin Resources Inc. (2.39%), Perceptive Advisors LLC (2.33%) and Orbimed Advisors LLC (1.60%). Company insiders that own Minerva Neurosciences stock include & Johnson Johnson, Care Capital Iii Llc, David Kupfer, Frederick W Ahlholm, Geoff Race, Joseph H Reilly, Mark S Levine, Remy Luthringer, Rubertis Francesco De and Venture Associates L Index III.
Who sold Minerva Neurosciences stock? Who is selling Minerva Neurosciences stock?
Minerva Neurosciences' stock was sold by a variety of institutional investors in the last quarter, including Highland Capital Management LP, Renaissance Technologies LLC, J. Goldman & Co LP and Franklin Resources Inc.. Company insiders that have sold Minerva Neurosciences stock in the last year include Frederick W Ahlholm, Geoff Race, Joseph H Reilly, Mark S Levine, Remy Luthringer and Venture Associates L Index III.
Who bought Minerva Neurosciences stock? Who is buying Minerva Neurosciences stock?
Minerva Neurosciences' stock was bought by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Russell Investments Group Ltd., State Street Corp, Oxford Asset Management, Marshall Wace LLP and AQR Capital Management LLC. Company insiders that have bought Minerva Neurosciences stock in the last two years include & Johnson Johnson, David Kupfer and Rubertis Francesco De.
How do I buy Minerva Neurosciences stock?
Shares of Minerva Neurosciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Minerva Neurosciences stock cost?
One share of Minerva Neurosciences stock can currently be purchased for approximately $9.40.